Wang et al. and Joseph et al. showed that the PPARγ/LXRα/ABCA1 pathway is activated by natural or synthetic agonists, which upregulates ABCA1 expression, enhances cell cholesterol efflux, and reduces atherosclerosis development [32,33]. The gene discussed is NR1H3; the disease is atherosclerosis.